BSE filing, NSE: CHEMFAB. Summary written from the filing by ALFA Finder's alert engine.
Chemfab Alkalis Ltd: key numbers
- Share price
- ₹305.05
- Market cap
- ₹438.5 Cr
- Revenue (annual)
- ₹311.0 Cr
- Net profit (annual)
- ₹-3.43 Cr
- P/E (TTM)
- -1799.9×Sector 34.5×
- Promoter holding
- 72.13%+0.00% QoQ
- FII holding
- 0.04%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chemfab Alkalis Ltd
All →Chemfab Alkalis Management Change
Chemfab Alkalis approved unaudited Q2/H1 results, committee re-designations, and appointed V. R. Raguraman as Chief Operating Officer (SMP). The senior management appointment is the filing's main business event.
Chemfab Alkalis Q2 FY27 Results: Net Loss of ₹2.1 Cr, Loss Widens
Chemfab Alkalis Ltd reported revenue from operations of ₹75.6 Cr (-1.3% YoY) and a net loss of ₹2.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹2.1 Cr
Chemfab Alkalis Other Announcement
Chemfab Alkalis Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing discloses the company's equity distribution as per Regulation 31.
Chemfab Alkalis Credit Rating
India Ratings affirmed Chemfab Alkalis' bank loan facilities at IND BBB+/Negative. The action reflects expected operational recovery against a still-stretched liquidity position.
Chemfab Alkalis Other Announcement
Chemfab Alkalis Limited's shareholders approved the appointment of M/s. MSKC & Associates LLP as Statutory Auditors for a five-year term at the 17th AGM.
Chemfab Alkalis Annual General Meeting
Chemfab Alkalis held its 17th Annual General Meeting on September 9, 2026. Shareholders transacted ordinary and special business as set out in the notice.
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.